Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (71-80 of 375) with videos related to

Pageof 38
Sort By:
International Journal of Antimicrobial Agents|November 5, 2023
HIV-1 resistance mutations to integrase inhibitors impair both integration and reverse transcription stepsPauline Ratouit, Isabelle Malet, Cathia Soulie, et al.
AIDS (London, England)|June 17, 2004
Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failuresChristophe Piketty, Laurence Gérard, Corine Chazallon, et al.
Biomedicines|May 28, 2022
A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical StudyPhilippe A Grange, Guillaume Ollagnier, Laurianne Beauvais Remigereau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Human retrovirus-5 and Sjögren's syndromePhilippe Bossi, Serge Perrot, Nicolas Dupin, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patientsMartin S King, Richard Rode, Isabelle Cohen-Codar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Corine Chazallon, Laurence Gérard, et al.
Mbio|May 31, 2018
Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir"Isabelle Malet, Frédéric Subra, Clémence Richetta, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudineConstance Delaugerre, Anne-Geneviève Marcelin, Vincent Thibault, et al.
AIDS (London, England)|June 5, 2007
Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological surveyConstance Delaugerre, Anne-Genevieve Marcelin, Cathia Soulié, et al.
Plos Biology|February 8, 2019
Modeling Edar expression reveals the hidden dynamics of tooth signaling center patterningAlexa Sadier, Monika Twarogowska, Klara Steklikova, et al.
Pageof 38

Showing results (71-80 of 375) with videos related to

Sort By:
Pageof 38
International Journal of Antimicrobial Agents|November 5, 2023
HIV-1 resistance mutations to integrase inhibitors impair both integration and reverse transcription stepsPauline Ratouit, Isabelle Malet, Cathia Soulie, et al.
AIDS (London, England)|June 17, 2004
Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failuresChristophe Piketty, Laurence Gérard, Corine Chazallon, et al.
Biomedicines|May 28, 2022
A New Topical Candidate in Acne Treatment: Characterization of the Meclozine Hydrochloride as an Anti-Inflammatory Compound from In Vitro to a Preliminary Clinical StudyPhilippe A Grange, Guillaume Ollagnier, Laurianne Beauvais Remigereau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Human retrovirus-5 and Sjögren's syndromePhilippe Bossi, Serge Perrot, Nicolas Dupin, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patientsMartin S King, Richard Rode, Isabelle Cohen-Codar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Corine Chazallon, Laurence Gérard, et al.
Mbio|May 31, 2018
Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir"Isabelle Malet, Frédéric Subra, Clémence Richetta, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudineConstance Delaugerre, Anne-Geneviève Marcelin, Vincent Thibault, et al.
AIDS (London, England)|June 5, 2007
Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological surveyConstance Delaugerre, Anne-Genevieve Marcelin, Cathia Soulié, et al.
Plos Biology|February 8, 2019
Modeling Edar expression reveals the hidden dynamics of tooth signaling center patterningAlexa Sadier, Monika Twarogowska, Klara Steklikova, et al.
Pageof 38